Nalaganje...
The current treatment strategy for gouty arthritis
Febuxostat is a non-purine selective inhibitor of isoforms of xanthine oxidoreductase (XOR), the effect of which is aimed at lowering the level of serum uric acid (UA). Febuxostat is a more potent inhibitor of XOR than allopurinol, as confirmed by that target UA levels have been achieved more freque...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
IMA-PRESS LLC
2018-09-01
|
| Serija: | Современная ревматология |
| Teme: | |
| Online dostop: | https://mrj.ima-press.net/mrj/article/view/844 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|